West Nile virus alarmed Americans when it made its first U.S. appearance in New York City in 1999. It has since spread from coast to coast, sickened more than 16,000 Americans and killed more than 600. As the virus spread, medical investigators hastened research to develop an effective vaccine or therapy. None currently exist, but a newly published paper by researchers at Washington University in St. Louis points to a promising treatment. This research, published today online by Nature Medicine, was funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The research team developed an infection-fighting antibody that mimics one produced by people whose immune systems successfully fend off the West Nile virus. The researchers tested their antibody in mice and say its success warrants further development and testing in people with West Nile disease.
"West Nile virus has emerged in the United States as a regular seasonal threat, particularly for people over 50. We currently do not have a proven therapy for people with serious West Nile disease, so we will continue to aggressively pursue all promising leads for an effective treatment," says Anthony S. Fauci, M.D., director of NIAID.
Scientists do not know why some people infected with West Nile virus have no symptoms or a mild flu-like illness, while in others the virus invades the central nervous system and causes paralysis or coma. "We could give this antibody to mice as long as five days after infection, when West Nile virus had entered the brain, and it could still cure them," says Washington University senior investigator Michael Diamond, M.D., Ph.D., who headed the research team, which is supported in part by the NIAID-funded Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases. "It also completely protected the mice against death."
The researchers decided to develop the potentialPage: 1 2 Related biology news :1
. Another Look Finds Promising Proteomics Test is Not Biologically Plausible2
. Promising therapies for haemophilia & heart disease3
. Promising cell protein may play role in infection and dry eye4
. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer5
. Columbia research lifts major hurdle to gene therapy for cancer6
. Combination therapy boosts effectiveness of telomere-directed cancer cell death7
. Gene therapy converts dead bone graft to new, living tissue8
. Study identifies predictors of HIV drug resistance in patients beginning triple therapy9
. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows10
. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice11
. New therapy for HIV/AIDS eliminates needles and excessive toxicity